Chronic Cancer Pain Management Program
CompletedNot applicableNCT06101849
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
The goal of this research study is to evaluate an online inter-professional pain management program for survivors of breast cancer. The main questions it aims to answer: 1. whether this treatment will help address the pain management concerns of patients, 2. whether it is feasible to offer this treatment in the future as multi-centre randomized controlled trial (RCT). Participants will be asked to attend a 6-week online pain management group sessions (1h/week). Participants will also be asked to fill out questionnaires before and after the program completion.
Study details
- Official title
- Evaluating an Online Interprofessional Chronic Pain Management Group for Survivors of Breast Cancer: A Feasibility Study of a Randomized Controlled Trial
- Conditions
- Breast Cancer
- Cancer, Treatment-Related
- Pain Cancer
- Interventions
- Behavioral: I-Can-Manage-Pain after cancer (Pain Management Program)
- Sponsor
- Hamilton Health Sciences Corporation
- Collaborators
- McMaster University
- Start date
- 2024-01-03
- Primary completion
- 2025-03-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. diagnosis of Stage 1-3 breast cancer; 2. had surgical excision at least 3 months ago; 3. completed neoadjuvant/adjuvant chemotherapy and/or radiation treatment at least 4 months ago; 4. within 5 years post active cancer treatment; 5. persistent pain within the last 3 months that is bothersome; 6. medical clearance to participate in the intervention 7. over 18 years of age; 8. verbal fluency in English; 9. have access to internet and technology to participate in the online program. Patients currently receiving adjuvant endocrine therapy or molecularly targeted therapies or who have completed these therapies within the last 5 years are eligible to participate. Exclusion Criteria: * Participants will be excluded from the study if they: 1. demonstrate significant cognitive impairment as determined by the clinical judgment of the provider; 2. have a pre-existing non-cancer pain condition, 3. have severe emotional distress that interferes with group participation as determined by scores above 15 on the Patient Health Questionnaire-9.
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06101849